Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Umbilical cords are a potentially life-saving source of blood stem cells for people with leukemia and other diseases. But there aren’t enough cells to meet demand. Now an experimental treatment offers hope for a solution.

Researchers discover that networks of proteins circulating in the blood influence the development and progression of chronic diseases.

A lung cancer researcher describes her journey toward a career in science at Novartis.

Meet a Senior Medical Director at Novartis who is part of our new “Women in Science” series

A middle school student curious about science grows into a college-bound scientist.

Compound offers a potential tool for fighting drug-resistant malaria parasites.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.